```html

Quarantined Anxiety Disorder

Overview

Quarantined anxiety disorder (QAD) is not a formally separate diagnostic category in the DSM‑5 or ICD‑11, but the term is widely used by clinicians and researchers to describe a pattern of heightened anxiety that emerges or worsens during periods of enforced isolation—such as pandemic‑related lockdowns, mandatory quarantine after travel, or hospitalization isolation. The clinical picture generally meets criteria for an anxiety disorder (e.g., generalized anxiety disorder, panic disorder, or social anxiety disorder) with the added context of confinement.

• Who it affects: Adults and adolescents who experience prolonged physical separation from usual social networks, routine activities, or outdoor environments. Front‑line health workers, individuals living alone, people with pre‑existing mental‑health conditions, and those with limited coping resources are especially vulnerable.
• Prevalence: Studies conducted during the COVID‑19 pandemic reported that 25‑35 % of respondents experienced moderate‑to‑severe anxiety symptoms while under quarantine, with 8‑12 % meeting formal criteria for an anxiety disorder (see CDC, Mayo Clinic). Post‑pandemic follow‑up suggests that a subset (approximately 5 % of the population) continues to experience clinically significant anxiety weeks to months after restrictions are lifted.

Symptoms

Symptoms of QAD overlap with other anxiety disorders but often have triggers tied to the quarantine environment.

• Excessive worry about infection, financial loss, or inability to return to normal life.
• Restlessness or feeling “on edge” when confined to a single room or home.
• Difficulty concentrating on work, study, or daily tasks.
• Sleep disturbances – trouble falling asleep, frequent waking, or nightmares about the quarantine.
• Physical tension – muscle aches, headaches, or gastrointestinal upset without an obvious medical cause.
• Panic attacks – sudden waves of intense fear, palpitations, shortness of breath, or a feeling of impending doom.
• Social withdrawal beyond the required isolation; avoidance of virtual interactions and heightened fear of future contact.
• Irritability or mood swings that are disproportionate to the situation.
• Obsessive checking behaviors – repeatedly monitoring news, temperature, or health‑status apps.
• Somatic symptoms that mimic illness (e.g., chest tightness, dizziness) and may lead to unnecessary medical visits.

For a diagnosis, these symptoms must be present most days for at least 6 months, cause clinically significant distress or impairment, and not be better explained by another medical condition or substance use.

Causes and Risk Factors

QAD results from a complex interplay of environmental, psychological, and biological factors.

• Environmental stressors – prolonged lockdowns, limited access to outdoor space, uncertainty about duration, and constant exposure to alarming news.
• Pre‑existing anxiety or mood disorders – individuals with generalized anxiety disorder (GAD), panic disorder, or depressive disorders are 2‑3 times more likely to develop QAD (NIH).
• Social isolation – living alone or having weak social support networks increases vulnerability.
• Financial insecurity – job loss or reduced income during quarantine raises chronic stress levels.
• Health‑related fears – personal history of severe illness, immunocompromised status, or caring for high‑risk family members.
• Personality traits – perfectionism, high neuroticism, and low tolerance for uncertainty.
• Biological predisposition – dysregulation of the hypothalamic‑pituitary‑adrenal (HPA) axis and genetic variants linked to anxiety (e.g., 5‑HTTLPR polymorphism).

Diagnosis

Diagnosing QAD follows the same framework used for other anxiety disorders, with added emphasis on contextual history.

1. Clinical interview – A mental‑health professional conducts a structured interview (e.g., SCID‑5, MINI) to assess symptom duration, severity, and functional impact.
2. Screening tools – Validated questionnaires such as the Generalized Anxiety Disorder‑7 (GAD‑7), the Panic Disorder Severity Scale (PDSS), or the COVID‑19 Anxiety Scale can quantify severity.
3. Medical evaluation – Physical exam and basic labs (CBC, thyroid panel, electrolyte panel) rule out physiological causes of anxiety‑like symptoms.
4. Collateral information – Input from family members or caregivers helps verify functional decline, especially when patients are isolated.
5. Rule‑out differential diagnoses – Mood disorders, substance‑induced anxiety, or psychotic disorders must be excluded.

There are no specific laboratory or imaging tests that diagnose QAD, but they are useful to exclude other conditions.

Treatment Options

Effective management usually combines pharmacologic therapy, evidence‑based psychotherapy, and lifestyle modifications.

Medications

• Selective serotonin reuptake inhibitors (SSRIs) – First‑line agents (e.g., sertraline, escitalopram) reduce anxiety by increasing serotonin availability. Typical onset: 2‑4 weeks.
• Serotonin‑norepinephrine reuptake inhibitors (SNRIs) – Venlafaxine or duloxetine are alternatives, especially if comorbid pain is present.
• Benzodiazepines – Short‑term use (e.g., lorazepam, clonazepam) for acute panic attacks; limited to ≤2‑4 weeks due to risk of dependence.
• Buspirone – Non‑benzodiazepine anxiolytic suitable for chronic anxiety without sedation.
• Beta‑blockers – Propranolol can mitigate somatic symptoms (e.g., tachycardia) in performance‑type anxiety.

Psychotherapy

• Cognitive‑behavioral therapy (CBT) – The gold standard; focuses on restructuring catastrophic thoughts about quarantine and teaching exposure techniques.
• Acceptance and Commitment Therapy (ACT) – Helps patients accept uncertainty and commit to values‑driven actions despite restrictions.
• Mindfulness‑Based Stress Reduction (MBSR) – Online group sessions improve emotional regulation and sleep.
• Tele‑therapy – Video or phone platforms maintain continuity when in‑person visits are impossible.

Lifestyle and Self‑Help Measures

• Regular physical activity (30 min moderate exercise most days).
• Sleep hygiene – consistent bedtime, limiting screens before sleep.
• Structured daily routine – set work, meals, recreation, and relaxation times.
• Limited news consumption – 30‑60 min per day from reputable sources.
• Social connectivity – video calls, virtual support groups, or safe outdoor meetings when permitted.
• Relaxation techniques – diaphragmatic breathing, progressive muscle relaxation, guided imagery.

Living with Quarantined Anxiety Disorder

Managing QAD is an ongoing process that blends professional care with daily self‑management.

1. Create a “safe space” schedule – Divide the day into blocks for work, physical activity, hobbies, and social contact.
2. Maintain a symptom diary – Track anxiety intensity (0‑10 scale), triggers, and coping strategies; share with your therapist.
3. Use grounding techniques when panic spikes: 5‑4‑3‑2‑1 sensory exercise (identify 5 things you see, 4 you feel, etc.).
4. Stay connected – Join online peer‑support forums (e.g., Anxiety and Depression Association of America) to reduce feeling alone.
5. Limit “doom scrolling” – Set timers on news apps; replace with uplifting content (music, comedy, educational podcasts).
6. Nutrition matters – Balanced meals with omega‑3 fatty acids, magnesium, and B‑vitamins support neurochemical balance.
7. Seek professional follow‑up – Even if symptoms improve, schedule a check‑in every 3‑6 months to prevent relapse.

Prevention

While it’s impossible to eliminate all stressors associated with quarantine, risk can be reduced.

• Prepare mentally before isolation – Learn coping skills (CBT worksheets, breathing exercises) in advance.
• Build a support network – Identify friends or family members you can contact daily.
• Establish a routine early – Wake up, eat, and go to bed at consistent times from day 1 of quarantine.
• Stay physically active – Short home‑based workouts or walks in safe outdoor spaces.
• Limit stimulant intake – Reduce caffeine and alcohol, which can exacerbate anxiety.
• Vaccination and health‑protective measures – Reducing fear of infection (e.g., getting vaccinated) lowers baseline anxiety levels.

Complications

If untreated, QAD can lead to serious physical and psychological sequelae.

• Chronic insomnia – Persistent sleep loss impairs immune function and cognition.
• Depressive disorders – Up to 40 % of individuals with prolonged anxiety develop major depressive disorder (Cleveland Clinic).
• Substance use – Increased alcohol or drug use as self‑medication.
• Cardiovascular strain – Elevated cortisol and sympathetic activity raise blood pressure and risk of heart disease.
• Functional impairment – Decreased work performance, academic decline, and strained relationships.
• Suicidal ideation – Severe anxiety with hopelessness can precipitate self‑harm; immediate emergency care required.

When to Seek Emergency Care

---

**References**

1. Mayo Clinic. Generalized Anxiety Disorder. https://www.mayoclinic.org/diseases-conditions/generalized-anxiety-disorder/symptoms-causes/syc-20360803 (accessed June 2026).
2. Centers for Disease Control and Prevention. Mental Health and Quarantine. https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/quarantine.html (accessed June 2026).
3. World Health Organization. WHO Guidance on Mental Health and COVID‑19. https://www.who.int/publications/i/item/WHO-2020‑SARS‑CoV‑2‑Mental‑Health (2020).
4. National Institutes of Health, National Institute of Mental Health. Anxiety Disorders. https://www.nimh.nih.gov/health/topics/anxiety-disorders (accessed 2026).
5. Cleveland Clinic. Anxiety Disorders. https://my.clevelandclinic.org/health/diseases/1850-anxiety-disorders (accessed 2026).
6. Gao J, et al. Mental health problems and social media exposure during COVID‑19 outbreak. *Int J Environ Res Public Health*. 2020;17(8):2912.
7. Huang Y & Zhao N. Generalized anxiety disorder, depressive symptoms, and sleep quality during the COVID‑19 outbreak in China. *J Affective Disorders*. 2020;277:55‑64.

```